Bibliographic Details
| Title: |
Mycoplasma pneumoniae y resistencias a macrólidos: ¿Conocemos la situación en Europa? |
| Alternate Title: |
Macrolide-resistant Mycoplasma pneumoniae: Do we know the situation in Europe? |
| Authors: |
Álvaro Varela, Ana Isabel1,2 ai.alvaro.varela@navarra.es, Aguinaga Pérez, Aitziber1,2, Navascués Ortega, Ana1,2, Castilla Catalán, Jesús2,3,4, Baquedano, Carmen Ezpeleta1,2 |
| Source: |
Revista Española de Quimioterapia. jun2023, Vol. 36 Issue 3, p259-296. 38p. |
| Abstract (English): |
Mycoplasma pneumoniae is a bacterium that lacks a cell wall. It produces infections all It produces infections worldwide, in epidemic outbreaks every 4-7 years, or endemically. Its clinical manifestations occur mostly in the respiratory tract and it is a common cause of atypical pneumonia. The treatment is with macrolides, tetracyclines or fluoroquinolones. Since 2000, an increase in resistance to macrolides has been detected worldwide, being more frequent in Asia. In Europe the frequency of resistance ranges between 1% and 25%, depending on the country. Molecular techniques and serology techniques provides very high sensitivity in diagnostic confirmation, being very useful for detecting and controlling M. pneumoniae outbreaks. The detection of resistance to macrolides requires a sequencing technique. [ABSTRACT FROM AUTHOR] |
| Abstract (Spanish): |
Mycoplasma pneumoniae es una bacteria que carece de pared celular. Produce infecciones en todo el mundo, en brotes epidémicos cada 4-7 años, o en forma endémica. Sus manifestaciones clínicas se producen mayoritariamente en el tracto respiratorio y es una causa común de neumonía atípica. El tratamiento se realiza con macrólidos, tetraciclinas o fluoroquinolonas. Desde el año 2000 se ha detectado un aumento de resistencias a macrólidos a nivel mundial, siendo más frecuentes en Asia. En Europa la frecuencia de resistencias oscila entre el 1% y 25% en diferentes países. La combinación de técnicas moleculares y serológicas aporta una alta sensibilidad en la confirmación diagnóstica, siendo de gran utilidad para la detección y control de brotes de M. pneumoniae. La detección de resistencia a macrólidos requiere una técnica de secuenciación. [ABSTRACT FROM AUTHOR] |
|
Copyright of Revista Española de Quimioterapia is the property of Sociedad Espanola de Quimioterapia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
MedicLatina |
